1 Global Biostorage Service Market Insight Analysis
The global Biostorage Service market revenue is expected to be USD 571.49 million in 2025, with a CAGR of 15.64% from 2025 to 2033.
Biostorage service refers to the storage and management of biological materials such as cells, tissues, blood, DNA, and other biological samples under controlled conditions to maintain their viability, stability, and integrity. These services typically involve the use of specialized equipment and facilities, such as freezers, refrigerators, liquid nitrogen tanks, and temperature monitoring systems, to maintain the samples at specific temperature ranges and conditions. Biostorage services are critical for various research, clinical, and diagnostic applications, where the quality and availability of biological samples are paramount.
Figure Global Biostorage Service Market Size (M USD) and CAGR (2025-2033)
2 Biostorage Service Market Growth Drivers and Restraints
In terms of driving factors, first of all, the growth of medical and scientific research demand is the key driving force. With the rising prevalence of chronic diseases such as cancer and diabetes, the demand for research on related diseases has led to an increase in the demand for biological sample storage. Biobanks and biorepositories play an important role in the development of new treatments and therapies. The rise of personalized medicine is also crucial. It provides customized treatments based on individual genetic characteristics, which requires a large number of high-quality biological samples to support, driving the growth of demand for biological storage services.
At the same time, the progress of genomic research has generated massive data, and the demand for high-quality biological samples is also increasing, further stimulating the biological storage service market. Technological progress and service diversification are also important driving factors. With the development of technology, storage facilities are constantly upgraded, and the services provided by biological storage service providers are becoming increasingly diversified. In addition to traditional biobank and biorepository services, it also provides services such as biomarker detection, professional laboratory services, and cell therapy product manufacturing and storage, which meet the diverse needs of different customers and expand the market space.
Emerging markets have great potential. Emerging economies such as China and India are developing rapidly, and the medical and pharmaceutical industries are booming. The demand for biobanks and biological storage services continues to grow. Government policy support, such as China’s increased investment in the healthcare industry and strengthening of relevant legislation, has created favorable conditions for the development of the biostorage service market.
However, market growth also faces many limiting factors. Capital and technical barriers are a major challenge. The biostorage service industry requires professional equipment and facilities to store biological samples. The equipment procurement and maintenance costs are high. For small companies or start-ups, it is difficult to invest in funds and technology. Moreover, the industry has high requirements for technical level. Companies need to keep up with the latest technological advances and regulatory requirements, which increases the difficulty and cost of corporate operations.
Strict regulatory supervision has also restricted market development to a certain extent. The biostorage service industry is strictly regulated. For example, the relevant regulations of the US Food and Drug Administration (FDA) and the European Union have strict requirements on corporate facilities, equipment, personnel and sample management. Once a company violates the regulations, it will face fines, legal proceedings and other consequences. This places high demands on corporate compliance operations and increases corporate operating costs and risks.
In addition, operational risks cannot be ignored. Biostorage service companies need to ensure the safety and confidentiality of samples, prevent sample damage or information leakage, and at the same time ensure sample quality and integrity and establish a sound quality management system. This places high demands on the company’s management capabilities. Poor management may lead to disputes and legal issues, affecting the company’s reputation and operations.
3 Technological Innovations in the Biostorage Service Market
In terms of technological innovation, intelligence and informatization have become important trends. With the development of technologies such as the Internet of Things and big data, the biological storage service industry is moving towards intelligent sample management and information interconnection. The fully automatic sample library can realize the automatic storage and retrieval of samples, reduce human errors and cross-contamination, and combine information technology and automated equipment to accurately manage inventory and improve sampling efficiency.
Some companies use the Internet of Things technology to achieve remote monitoring and management of storage equipment, grasp the operating status of equipment and sample storage conditions in real time, and ensure sample safety. In addition, storage technology is constantly upgraded. In order to meet the needs of long-term and high-quality storage of biological samples, companies continue to innovate in storage technology. Ultra-low temperature storage technology is constantly improving, which can better maintain the biological activity and stability of samples. The research and development of new storage materials and equipment is also in progress, such as storage containers with better thermal insulation performance, which can reduce energy consumption and improve storage efficiency.
Corporate mergers and acquisitions and restructuring activities have had an important impact on the market. Through mergers and acquisitions, companies can achieve resource integration and business expansion. For example, Azenta acquired Barkey Holding GmbH and its subsidiaries. Barkey has extensive experience in automated thawing of plasma, blood and stem cells. This acquisition expanded Azenta’s cold chain capabilities, enhanced its influence in the cell and gene therapy market, and improved its customer coverage and service capabilities.
Similarly, Cryoport acquired Cell&Co BioServices and MVE Biological Solutions. By integrating the resources and technologies of these companies, Cryoport is able to provide more comprehensive and improved temperature-controlled supply chain solutions to meet the growing needs of the life science industry and consolidate its competitive position in the market.
4 Global Biostorage Service Market Size by Type
Ambient storage refers to storing biological samples at normal environmental temperatures. In 2025, the revenue from ambient storage services is forecasted to be 58.91 million US dollars, accounting for 10.31% of the total biostorage service market revenue. This type of storage is suitable for certain samples that are relatively stable at room temperature, such as some dried biological materials or samples that require short – term storage under non – critical temperature conditions. Although its share is relatively small compared to other types, it still plays a role in specific applications within the biostorage market.
Refrigerated and frozen storage is a widely – used method in biostorage. In 2025, it is expected to generate a revenue of 223.04 million US dollars, which makes up 39.03% of the total market revenue. This type of storage covers a range of temperatures from slightly above freezing to sub – zero temperatures. It is essential for storing many biological samples like blood products, some tissue samples, and certain biological reagents. The ability to maintain samples at these temperatures helps preserve their biological activity and integrity for a moderate to long – term period, which is crucial for applications in medical research, diagnostics, and drug development.
Ultra – low storage involves maintaining extremely low temperatures, typically using liquid nitrogen or other cryogenic methods. In 2025, the revenue from ultra – low storage services is estimated to be 185.59 million US dollars, accounting for 32.48% of the market share. This type of storage is vital for storing highly sensitive biological materials such as stem cells, sperm, and oocytes, where maintaining the lowest possible temperature is necessary to ensure long – term viability and prevent degradation. It is also widely used in advanced research fields like regenerative medicine and genomics, where the integrity of samples is of utmost importance.
Table Global Biostorage Service Market Size and Share by Type in 2025
Type | Market Size (M USD) 2025 | Market Share 2025 |
|---|---|---|
Ambient Storage | 58.91 | 10.31% |
Refrigerated and Frozen Storage | 223.04 | 39.03% |
Ultra-low Storage | 185.59 | 32.48% |
Others | 103.95 | 18.19% |
5 Global Biostorage Service Market Size by Application
Life Sciences and Medicine is the leading application area in the biostorage service market. In 2025, it is projected to generate a revenue of 292.46 million US dollars, accounting for 51.17% of the total market revenue. This dominant position is mainly due to the increasing demand for biostorage in research and development of new drugs, genetic testing, and personalized medicine. With the continuous progress of life – science research, the need to store biological samples such as DNA, RNA, and cells for long – term analysis has soared.
Hospitals are the second – largest application segment. In 2025, hospitals are expected to contribute 112.35 million US dollars in revenue to the biostorage service market, holding a share of 19.66%. Hospitals require biostorage services for storing patient samples for diagnostic purposes, disease monitoring, and clinical trials. The growth in the number of patients and the expansion of medical services have led to an increased demand for reliable biostorage solutions within hospital settings.
Government and Scientific Research Institutions follow closely. Their revenue from biostorage services in 2025 is forecasted to be 88.67 million US dollars, making up 15.52% of the total market. These institutions engage in a wide range of research projects, from basic scientific research to environmental and agricultural studies. They need to store large quantities of samples, including soil samples, water samples, and biological specimens from various organisms, which drives the demand for biostorage services.
The Chemical Industry also contributes to the biostorage service market. In 2025, it is estimated to generate a revenue of 36.96 million US dollars, accounting for 6.47% of the market share. The chemical industry uses biostorage for storing biological catalysts, enzymes, and other biological materials used in chemical synthesis processes.
Table Global Biostorage Service Market Size and Share by Application in 2025
Application | Market Size (M USD) 2025 | Market Share 2025 |
|---|---|---|
Life Sciences and Medicine | 292.46 | 51.17% |
Hospital | 112.35 | 19.66% |
Government and Scientific Research Institutions | 88.67 | 15.52% |
Chemical Industry | 36.96 | 6.47% |
Others | 41.05 | 7.18% |
6 Global Biostorage Service Market Size by Region
North America stands as a dominant region in the biostorage service market. In 2025, its revenue is forecasted to reach 229.19 million US dollars, accounting for 40.10% of the total market share. This region’s leadership can be attributed to several factors. It boasts a highly developed healthcare and life – science research infrastructure.
The United States, in particular, is home to numerous top – tier research institutions, pharmaceutical giants, and advanced medical facilities. These entities drive a high demand for biostorage services, whether it’s for storing biological samples for drug development, genetic research, or clinical trials. Additionally, North America has a robust funding ecosystem for scientific research, enabling continuous investment in biostorage technologies and facilities.
Europe is another significant player in the biostorage service market. In 2025, the region’s revenue is expected to be 153.66 million US dollars, holding a market share of 26.89%. Europe has a long – standing tradition of excellence in scientific research and a well – established network of research centers and universities. Countries like the United Kingdom, Germany, and France have been at the forefront of life – science research, which fuels the demand for biostorage services.
Moreover, the European Union’s initiatives in promoting research and innovation in healthcare and biotechnology have further stimulated the growth of the biostorage market in the region. However, regulatory differences among European countries can sometimes pose challenges to the seamless expansion of biostorage service providers.
The Asia Pacific region is emerging as a rapidly growing area in the biostorage service market. In 2025, its revenue is projected to be 148.13 million US dollars, with a market share of 25.92%. The region’s growth is driven by several factors. Economies like China and India are experiencing rapid economic development, leading to increased investment in healthcare and life – science research.
There is a growing awareness of the importance of biostorage for medical advancements, such as personalized medicine and disease prevention. Additionally, government support in the form of policies and funding for biotechnology research is fueling the demand for biostorage services. As the region continues to develop its scientific and technological capabilities, its share in the global biostorage market is expected to further increase.
Latin America’s biostorage service market is relatively smaller but shows signs of growth. In 2025, the revenue is forecasted to be 18.05 million US dollars, accounting for 3.16% of the market share. Although the region faces challenges such as limited research funding compared to other regions, there is an increasing recognition of the value of biostorage in healthcare and agricultural research. Some countries in the region are gradually investing in building their biostorage infrastructure to support local research and development efforts.
The Middle East and Africa region’s biostorage service market revenue is projected to be 22.46 million US dollars in 2025, with a market share of 3.93%. This region has a mix of emerging economies with diverse needs. Some countries in the Middle East are investing in biotechnology research due to their economic resources, while in Africa, there is a growing focus on using biostorage for disease surveillance and agricultural improvement. However, challenges such as infrastructure limitations and uneven distribution of resources still need to be addressed for more significant growth in the biostorage service market.
Figure Global Biostorage Service Market Size (M USD) by Region in 2025
7 Global Biostorage Service Market Analysis by Major Players
Azenta
Company Profile: Azenta, established in 2011 and headquartered in the US, is a renowned name in the life sciences industry.
Business Overview: Azenta is dedicated to accelerating the discovery, development, and delivery of impactful breakthroughs and therapeutics for life sciences organizations worldwide. By integrating industry-leading capabilities, Azenta offers an enterprise-wide sample discovery and management solution that enhances the speed and precision of scientific advancements.
Product Offered: Azenta provides comprehensive storage solutions, including sample and material storage, with features like quality assurance (GxP compliance), fast access, and advanced informatics and technology solutions.
2023 Revenue Summary: In 2023, Azenta generated a substantial revenue of $66.60 million USD, marking it as a leader in the biostorage service market.
Cryoport
Company Profile: Cryoport, founded in 1990 and also headquartered in the US, is a global leader in temperature-controlled supply chain solutions for the life sciences industry.
Business Overview: Cryoport serves biopharmaceutical, IVF and surrogacy, and animal health organizations worldwide with its proprietary logistics management platform and condition monitoring system. It is known for its end-to-end supply chain expertise and 24/7 customer support.
Product Offered: The company offers storage services at various temperatures, including controlled room temperature, refrigerated, frozen, ultra-cold, and cryogenic storage, ensuring the safety and integrity of biological samples.
2023 Revenue Summary: Cryoport achieved a revenue of $49.90 million USD in 2023, solidifying its position as a major player in the biostorage service industry.
Avantor
Company Profile: Avantor, established in 1904 and headquartered in the US, is a leading global provider of mission-critical products and services to customers across various industries.
Business Overview: Avantor supports the biopharmaceutical, healthcare, education and government, and advanced technologies and applied materials industries. Its product portfolio is integral to research, development, and production activities in the served industries.
Product Offered: Avantor provides biorepository services, ensuring the safety of critical research assets through consolidated storage in a network of secure facilities with strict standards compliance.
2023 Revenue Summary: Avantor reported a revenue of $32.61 million USD in 2023, highlighting its significant role in the biostorage service market.